Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2020 Nov 26;30(2):105478. doi: 10.1016/j.jstrokecerebrovasdis.2020.105478

Table 3.

Associations with outcomes: adequate reperfusion (Thrombolysis in Cerebral Infarction, TICI 2b-3), intracerebral hemorrhage (ICH), and 90-day functional independence (modified Rankin scale, mRS 0–2). #All patients with occluded stents received at least one antiplatelet agent. Abbreviations: ICA internal carotid artery, DAPT dual antiplatelet therapy, OR odds ratio, CI confidence interval.

TICI 2b-3 ICH 90-Day mRS 0–2 Stent Patency
P OR (95%CI) P OR (95%CI) P OR (95%CI) P OR (95%CI)
Among Accessible ICAs (N=55)
 Dissection (15) vs Atherosclerosis 0.334 0.55 (0.16–1.85) 0.876 0.87 (0.16–4.88) 0.880 1.11 (0.30–4.10) - -
 Stenting (34) vs Not 0.874 0.91 (0.29–2.87) 0.475 1.86 (0.34–10.24) 0.479 0.64 (0.19–2.19) - -
 Cervical ICA First (34) vs Last/Deferring 0.347 0.57 (0.18–1.84) 0.138 5.19 (0.59–45.58) 0.879 1.10 (0.32–3.75) - -
 Number EVT Passes 0.163 0.65 (0.36–1.19) 0.167 0.44 (0.14–1.41) 0.641 0.87 (0.48–1.57) - -
Among Stented (N=34)
 Alteplase Treatment (27) 0.103 3.96 (0.76–20.67) 0.507 0.52 (0.08–3.56) 0.764 1.32 (0.21–8.24) 0.653 0.56 (0.04–7.21)
 Any Antiplatelet (23) 0.260 2.29 (0.54–9.63) 0.380 0.45 (0.07–2.68) 0.204 3.12 (0.54–17.97) 0.999 #
 Aspirin (20) 0.316 2.04 (0.51–8.23) 0.699 0.71 (0.12–4.11) 0.619 1.46 (0.33–6.46) 0.157 0.25 (0.04–1.70)
 DAPT (8) 0.981 0.98 (0.19–5.01) 0.507 1.92 (0.28–13.08) 0.774 1.28 (0.24–6.70) 0.781 1.33 (0.18–10.12)
 Eptifibatide (8) 0.396 0.50 (0.10–2.48) 0.507 1.92 (0.28–13.08) 0.568 0.59 (0.10–3.57) 0.463 0.47 (0.06–3.57)